Although RET fusions were rare variants in CRC, one study found that more than two-thirds of the patients with right hemizygous colon cancer, RAS/BRAF wt, and MSI-H in CRC carried RET gene fusions. This evidence concerns the gene RET and colorectal carcinoma.